SCHEMBL3210241

SCHEMBL3210241

COc1ccc(N(Cc2cncnc2)c2ccc(C(=O)OC(C)(C)C)cc2)cc1OC(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 2/20 0.39
RXRB P28702 1/20 0.39
RXRG P48443 1/20 0.39
PDE4B Q07343 2/20 0.36
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
MAPK1 P28482 1/20 0.36
PDE4A P27815 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34
HDAC6 Q9UBN7 1/20 0.33
ABL1 P00519 1/20 0.33
KCNH2 Q12809 1/20 0.33
USP2 O75604 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PAX8 Q06710 1/20 0.33
P2RX3 P56373 1/20 0.33
MTNR1A P48039 1/20 0.32
MTNR1B P49286 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3217020 0.92 SLC7A5 (0.37) RXRARXRBRXRGPDE4BALDH1A1
SCHEMBL3126325 0.91 RXRA (0.38) RXRARXRBRXRGPDE4BALDH1A1
SCHEMBL3203192 0.91 RXRA (0.42) RXRARXRBRXRGALDH1A1MAPT
SCHEMBL3212923 0.88 MAPK1 (0.39) PDE4BALDH1A1MAPTMAPK1PDE4A
SCHEMBL3125334 0.87 RXRA (0.52) RXRARXRBRXRGPDE4BALDH1A1
SCHEMBL3120270 0.87 PDE4A (0.38) RXRARXRBRXRGPDE4BMAPT
SCHEMBL3199311 0.86 RXRA (0.37) RXRARXRBRXRGPDE4BALDH1A1
SCHEMBL3192278 0.86 AAK1 (0.39) RXRARXRBRXRGPDE4BALDH1A1
SCHEMBL3126412 0.86 TSHR (0.42) ALDH1A1MAPTMAPK1HDAC6NPSR1
SCHEMBL3215234 0.85 PDE4B (0.40) PDE4BPDE4APDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS MEMORY PHARMACEUTICALS CORPORATION (US) 2010-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029689-A1 PHOSPHODIESTERASE 4 INHIBITORS PDE4A, PDE4B, PDE3B RXRA 2856/4885RXRB 2676/4885RXRG 3004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.